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Novelty and Impact Statement:  
Several modifiable lifestyle factors including smoking, alcohol, certain dietary factors 
and weight have been independently associated with gastric cancer. However, no 
study to date has investigated the combined impact of these behaviours, using a 
healthy lifestyle index, on gastric cancer risk. Our study indicates that adopting a 
combination of lifestyle behaviours, including not smoking, drinking within alcohol 
guidelines, following a healthy dietary pattern and having a normal weight 
dramatically decreases the burden of gastric cancer. 
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Abstract  
 
Several modifiable lifestyle factors, including smoking, alcohol, certain dietary factors 
and weight are independently associated with gastric cancer (GC); however, their 
combined impact on GC risk is unknown. We constructed a healthy lifestyle index to 
investigate the joint influence of these behaviours on GC risk within the European 
Prospective Investigation into Cancer and Nutrition (EPIC) cohort. The analysis 
included 461,550 participants (662 first incident gastric adenocarcinoma (GC) cases) 
with a mean follow-up of 11.4 years. A healthy lifestyle index was constructed, 
assigning 1 point for each healthy behaviour related to smoking status, alcohol 
consumption and diet quality (represented by the Mediterranean diet) for assessing 
overall GC and also body mass index for cardia GC, and 0 points otherwise. Risk of 
GC was calculated using Cox proportional hazards regression models while adjusting 
for relevant confounders.   
The highest versus lowest score in the healthy lifestyle index was associated with a 
significant lower risk of GC, by 51% overall (HR 0.49 95% CI 0.35, 0.70), by 77% for 
cardia GC (HR 0.23 95% CI 0.08, 0.68) and by 47% for non-cardia GC (HR 0.53 
(95% CI 0.32, 0.87), p-trends<0.001. Population attributable risk calculations showed 
that 18.8% of all GC and 62.4% of cardia GC cases could have been prevented if 
participants in this population had followed the healthy lifestyle behaviours of this 
index.  
Adopting several healthy lifestyle behaviours including not smoking, limiting alcohol 
consumption, eating a healthy diet and maintaining a normal weight is associated 
with a large decreased risk of GC.  
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Introduction 
Although incidence of gastric cancer (GC) is declining in many countries, it is still the 
fourth most common malignancy and the second leading cause of death due to 
cancer worldwide(1). In 2008, more than 990,000 incident cases were recorded 
(7.8% of new cancers) with 738,000 deaths. In addition, both early diagnosis and 
effective treatment still remain a challenge. There are a number of modifiable risk 
factors that are individually related to risk of developing GC, including smoking(2), 
alcohol drinking(3), dietary factors(4) and weight(5). As behavioural patterns often 
cluster together in everyday life, it is informative from a public health point of view to 
examine the combined impact of several lifestyle factors on health outcomes(6-15), 
especially when considering multi-factorial diseases  such as cancer, including 
GC(4;16).  
 
Smoking is an established risk factor of GC(2) and in previous analyses in the 
European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) 
there was a 45% higher risk of GC associated with ever compared to never 
smoking(17). With regards to alcohol, a recent meta-analysis found that heavy 
consumption was associated with an increased risk but moderate consumption was 
not(3). This was reflected in subsequent results from EPIC-EURGAST where 
≥60g/day of alcohol was associated with a 65% increased risk of GC(18). In addition 
there is mounting evidence that being overweight or obese is a risk factor for cardia 
GC, but it has not been associated with total GC, according to a recent meta-analysis 
including over 10 million people(5). 
 
With regards to diet, although the World Cancer Research Fund/American Institute of 
Cancer Research (WCRF/AICR) report concluded that there is as yet no convincing 
evidence about the relationship between dietary factors and GC, the Panel 
concluded that food and nutrition may play an important role in the prevention and 
causation of GC(4). Several foods characteristic of the Mediterranean dietary pattern 
have been related to a lower risk of GC in EPIC-EURGAST, including a high intake of 
fruit and vegetables(19) and cereal fibre(20) and low intake of red and processed 
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meat(21). In addition, we have observed that high adherence to a Mediterranean diet 
was associated with a 33% reduction in GC in the same population(22). 
 
In summary, there is considerable evidence that several modifiable lifestyle factors 
are individually associated with risk of GC; however to our knowledge no study has 
evaluated their combined impact specifically on GC, which is relevant since people’s 
behavioural patterns often cluster. We therefore evaluated the effects of a healthy 
lifestyle index, combining smoking status, alcohol consumption, diet quality evaluated 
on the basis of adherence to the Mediterranean dietary pattern and body mass index 
(BMI) (only in cardia GC analyses), on the risk of developing GC according to tumour 
site and histological type.  
 
MATERIAL AND METHODS 
 
Study subjects and data collection 
EPIC is a prospective cohort study designed to investigate the relationship between 
nutrition, dietary habits, lifestyle, genetic and environmental factors and cancer and 
other chronic diseases. It is an on-going cohort study across 23 centres in 10 
European countries (Denmark, France, Germany, Greece, Italy, the Netherlands, 
Norway, Spain, Sweden, and the United Kingdom) whose study design has been 
reported previously(23;24). In brief, 521,454 participants aged mostly 25-70 years old 
were recruited between 1992 and 2000 mainly from the general population within 
defined geographical or administrative areas, but with some exceptions(24). All study 
participants gave written informed consent and ethical approval was obtained from all 
participating centres and the International Agency for Research on Cancer (IARC).  
 
The habitual diet over the previous year was measured at recruitment through 
various methods, including validated country-specific questionnaires (semi-
quantitative food frequency or diet history questionnaires) or 7-day food 
records(24;25). Participants also filled in lifestyle questionnaires including information 
on education, occupation, physical activity, lifetime history of alcohol and tobacco 
consumption and reproductive and medical history. Anthropometric measures were 
taken by trained personal, apart from in France, Norway and Oxford where they were 
self-reported. 
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Definition of GC cases, study population and follow-up 
Vital status was obtained through periodic linkage to regional or national mortality 
registries. Incident GC cases were identified through population cancer registries, 
except for France, Germany and Greece where a combination of methods were 
used, as detailed previously(24). A total of 892 incident GC cases were reported to 
the central database at IARC up to September 2010. These stomach cancers include 
cancers coded as C16 (C16.0 for cardia and C16.1-16.6 for non-cardia), according to 
the 10th Revision of International Statistical Classification of Diseases, Injuries and 
Causes of Death (ICD). A panel of pathologists confirmed the diagnosis, 
classification of tumour site and morphology of the tumours for 81% of the cases 
(according to ICD02 Classification and to Lauren classification for histology)(26). 
Among the incident cases, 41 gastric lymphomas and 91 other non-adenocarcinoma 
GC were excluded, leaving 760 gastric adenocarcinomas.  
 
Of the initial 521,454 participants in the EPIC cohort, participants with prevalent 
cancer at recruitment and with incomplete follow-up (n=28,289) were excluded. 
Participants with missing dietary and lifestyle data (n=6,253) or with a ratio for energy 
intake versus energy expenditure in the top and bottom 1% (n=9,600) or missing 
information for the components used to construct the healthy lifestyle index were also 
excluded (n=15,762). Therefore, this current analysis is based on data from 461,550 
participants, including 662 incident GC. 
 
Healthy lifestyle index construction 
An a priori healthy lifestyle index was created based on current scientific 
knowledge(27) and public health recommendations of dietary/ lifestyle factors that 
are specifically related to GC(4). The lifestyle factors included i) smoking status, ii) 
alcohol consumption, and iii) diet quality evaluated with a modified version of the 
relative Mediterranean diet (rMED) score, which incorporates intakes of fruit, 
vegetables and meat products (dietary components especially relevant for 
GC(19;21)), as well as olive oil, legumes, dairy products, fish, seafood and cereals. 
The rMED score, whose construction has been described previously(22), was 
modified in this analysis to exclude alcohol since it is evaluated as a separate factor 
within the index. A fourth factor, BMI (largely reflecting lifestyle choices such as diet 
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and physical activity) was added to the index for the analyses of cardia GC, since 
there is strong evidence that being overweight or obese is a risk factor for cardia GC, 
but it has not been associated with non-cardia GC(5). Each lifestyle factor was 
scored dichotomously by assigning 1 or 0 points, depending on whether a healthy 
behaviour was followed or not. The healthy lifestyle behaviours were defined as i) 
never smoking or quitting >10 years before recruitment, ii) no or low consumption of 
alcohol (defined as ≤12.5g/d for women and ≤25.0g/d for men) in accordance with 
the WCRF/AICR guidelines(4), iii) >8 points on the rMED score (ranging from 0-16) 
and iv) being within a normal weight range (18.5 to <25.0kg/m2). The overall index 
was determined by summing all the points obtained from each lifestyle factor, to give 
an overall score from 0-3 for the overall GC index and 0-4 for cardia GC, with higher 
points indicating adherence to a greater number of healthy lifestyle behaviours. 
 
Statistical Analyses 
Analyses were performed using Stata version 10 (Statacorp, College Station, TX). 
The cohort’s baseline characteristics were assessed in relation to the healthy lifestyle 
index. The association between the healthy lifestyle index and GC was assessed 
using Cox proportional hazards regression models, and hazard ratios (HR) and 95% 
confidence intervals (CI) were calculated. The healthy lifestyle index was modelled 
as a categorical variable (each point representing a separate category, with 0 points 
as the reference), and as a continuous variable (for each 1-point increment in score). 
Age was used as the primary time variable, with entry time defined as age at 
recruitment and exit time defined as age at diagnosis of first GC for cases and for 
non-cases age at death, age at diagnosis of cancer other than GC or age at last 
complete follow-up, depending on which occurred first.  All models were stratified by 
sex and age at EPIC study entry, and by centre to control for country effects. The 
Cox models were adjusted for total energy intake (Kcal/day, continuous), education 
level (none, primary, secondary, technical, university, unknown), BMI (<25kg/m2, ≥25 
to <30kg/m2, ≥30kg/m2) (except for analyses of cardia GC since BMI is within the 
index and for non-cardia GC since BMI is not a risk factor) and physical activity 
level(28) (inactive, moderately inactive, moderately active, active, unknown). Cox 
models were run to assess the association between the entire healthy lifestyle index 
and overall GC, and GC by anatomical site (cardia/non-cardia) and histological type 
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of the tumours (intestinal/diffuse). The Wald statistic(29) was carried out to assess 
the homogeneity of risk by location and histologic type for each 1-point increment in 
score. Sex-specific models were fitted and effect modification by sex was tested 
using the log likelihood ratio test. Separate models were also fitted for each of the 
healthy lifestyle factors within the index (modelled as a binary variable with the 
unhealthy behaviour (0 points) as the reference), while mutually adjusting for the 
remaining lifestyle factors and also the potential confounding variables mentioned 
above. All models were tested for and satisfied the proportional hazards assumption.  
Population attributable risk (PAR) fractions(30) were estimated to quantify the 
proportion of GC cases that could have been avoided, assuming a causal 
relationship, if all the studied population had been in the healthiest category for all the 
healthy lifestyle behaviours within the index. The formula used(31) takes into account 
the observed multivariate adjusted hazard ratios of GC for category within healthy 
lifestyle index, and the prevalence of the exposure within the cases. Point estimates 
were calculated using the formula described by Rockhill et al(31) and bootstrap 
sampling (repeated 1000 times) was used to calculate the 95% CIs.  
 
Sensitivity analyses 
In sensitivity analyses physical activity was also incorporated into the healthy lifestyle 
index, since there is some evidence, albeit not conclusive(4), that physical activity 
might be associated with GC(32). A score of 0 was given to participants who were 
inactive or moderately inactive and 1 point to those who were moderately active or 
active (37,469 participants had unknown physical activity level and were excluded 
from this sensitivity analysis). In addition, the main models were repeated excluding 
the adjustment for physical activity, which may in part be an intermediate factor 
between established risk factors included in the index. Separate models were also 
created stratifying by level of educational attainment (none and primary school 
versus secondary school and above), to explore any potential differences in risk by 
education and its related factors. A further sensitivity analysis included waist 
circumference in the index instead of BMI, defined according to ATPIII criteria(33); 0 
points for a waist circumference >102cm for men and >88cm for women, and 1 point 
for a waist circumference below these sex specific cut-offs. The analyses were also 
repeated excluding i) the first two years of follow-up, in order to exclude GC cases 
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identified during this period, as they could have had pre-diagnostic symptoms which 
might have changed their dietary or lifestyle habits ,and ii) probable dietary miss-
reporters (157,232 participants including 214 GC cases excluded), defined using 
Goldberg criteria(34), to reduce BMI-related under-reporting.  
 
RESULTS 
During a mean follow-up of 11.4 (standard deviation 2.5) years, corresponding to 
5,097,499 accumulated person-years, a total of 662 GC (60% men) were identified 
among the 461,550 (30% male) participants. The distribution of cases across EPIC 
countries is shown in Table 1. The GC cases were classified according to their 
anatomical site, with 192 (29%) cases in the cardia, 315 (48%) cases in the distal 
stomach region (non-cardia) and 155 (23%) cases with an unknown location. 
According to the Lauren classification there were 213 (32%) diffuse GC, 197 (30%) 
intestinal GC and 252 (38%) cases with unknown histological type. Participants with 
a higher healthy lifestyle score were more likely to be female, and to have a lower 
total energy intake and lower physical activity level but a higher BMI (Table 2).  
 
The association between each individual lifestyle factor and risk of overall GC by 
anatomical location is shown in Table 3. Never smoking or quitting more than 10 
years previously compared to smokers was associated with a decreased risk of 
overall GC (HR 0.64, 95% CI 0.54, 0.75), non-cardia GC (HR 0.67,95% CI 0.53, 
0.86) and cardia GC (HR 0.56, 95% CI 0.41, 0.75). There was also a strong inverse 
association between alcohol intake (within compared to outside the recommended 
range) and overall GC, especially non-cardia GC (HR 0.74, 95% CI 0.56, 0.97), but 
no association was observed for cardia GC. In contrast, a high compared to low 
rMED score was only significantly related to cardia GC (HR 0.61, 95% CI 0.38, 0.97). 
Finally, for BMI (only included in the index for cardia GC analyses) a normal 
compared to non-normal weight was not associated with overall or non-cardia GC, 
but there was a lower, albeit non-significant, risk of cardia GC. 
 
The overall healthy lifestyle index was related to a large significant reduction in GC 
risk, reaching a 51% (95% CI 30% to 65%) lower risk associated with participants 
scoring 3 points (following all three healthy behaviours) compared to none (Table 4). 
Although this inverse association was stronger and only significant in men compared 
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to women, there was no evidence of effect modification by sex (p=0.767). The results 
by anatomical site showed the strongest association for cardia GC, with a 77% (95% 
CI 32, 92%) reduction associated with following all four healthy lifestyle behaviours( 
including a normal BMI) compared to none. There was no evidence of heterogeneity 
between cardia and non-cardia though (P=0.468). The results by histological type 
showed around a 50% significant lower risk of both diffuse and intestinal GC for 
participants with the highest score (P for heterogeneity = 0.877). The associations 
between each 1 point increment in the healthy lifestyle index and GC risk (overall and 
by location and type) were all significant (Table 4),with a 25% (p-trend <0.001) lower 
risk for overall GC. 
 
The PAR, proportion of GCs that could have been avoided if the entire cohort 
followed the healthiest behaviours in the index, was 18.8% (95% CI 0.2,  35.0) for all 
GC cases, 62.4% (95% CI 15.4, 90.2) for cardia GC and 10.2% (95% CI 16.4 , 33.0) 
for non-cardia GC. In sensitivity an analysis excluding the first two years of follow up 
there was a similar reduction in risk of GC associated with following all three healthy 
lifestyle behaviours compared to none (HR 0.53, 95% CI 0.32, 0.87). The risk 
estimates were slightly de-attenuated after excluding dietary miss-reporters from the 
analyses (for overall GC HR 0.40, 95% CI 0.27, 0.61 for 3 versus 0 points) and after 
adding physical activity to the index, particularly for non-cardia GC (HR 0.38, 95% CI 
0.20, 0.75). Only marginal changes in risk estimates were observed when waist 
circumference was substituted for BMI within the index and when physical activity 
was excluded from the covariates in the main Cox models (data not shown).  The risk 
estimates for GC for each 1-unit increase in the index were similar for participants 
with a lower (HR 0.77 95% CI 0.66, 0.90) compared to higher (HR 0.72 95% CI 0.63, 
0.88) educational attainment. 
 
DISCUSSION 
 
This large European prospective cohort study found that a high score on a healthy 
lifestyle index, based on key modifiable lifestyle behaviours related to GC aetiology, 
was associated with an approximately 50% lower risk of GC. The magnitude of the 
association was more pronounced for cardia GC when BMI was included in the 
index, with up to a 77% lower risk related to following four healthy lifestyle 
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behaviours. Assuming a causal relationship, then 19% of all GC cases and 62% of 
cardia GC could have been prevented in this population if all the participants had 
followed the healthiest lifestyle behaviours.  
 
These results are particularly relevant for clinical guidelines, taking into account the 
current limitations of other strategies to prevent GC, such as the treatment or 
eradication of Helicobacter pylori (Hp) infection; Hp vaccines are a future promise but 
still not available and massive Hp infection eradication therapy through antibiotics is 
not feasible or advisable for the general population(27). Consequently, one of the 
most effective ways to decrease the burden of GC at present appears to be through 
avoiding exposure to factors that increase risk and promoting factors related to 
reducing risk, as represented in the modifiable behaviours of the healthy lifestyle 
index.  
 
As this is the first study to assess the combined impact of associated healthy lifestyle 
behaviours on GC risk, we cannot directly compare our results with others. However, 
recent cohort studies have also found that adopting a combination of healthy lifestyle 
behaviours substantially reduces the risk of overall cancer or other cancers sites 
(12;13;15;35). For instance, a high healthy lifestyle score was related to a significant 
58% decreased risk of pancreatic cancer in the NIH-AARP study(12), a 30% 
reduction in colorectal cancer in the Danish Diet and Health Cohort Study(13) and a 
51% decreased risk of digestive cancers (including stomach) in the French E3N 
cohort (sub-cohort of EPIC)(35). The Women’s Health Initiative Observational Study 
also found large reductions in cancer risk from adhering to the American Cancer 
Society healthy lifestyle guidelines, with a significant 17% lower risk of any cancer, 
22% lower risk of breast cancer and 52% lower risk of colorectal cancer for a high 
versus low ACS score(15).   
 
The relationship between GC and the individual lifestyle factors within the index were 
consistent with previous findings in EPIC(17;18;22) and other studies(2-5). Current 
smoking appeared to have the greatest individual impact on risk of GC in this present 
study, in line with high risk attributed to smoking(2;17). Adhering to the 
Mediterranean diet was related to a lower risk of GC, restricted to cardia GC, while 
no or low consumption of alcohol was related to a lower risk of GC, particularly non-
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cardia GC. However, the impact of following the combined healthy behaviours within 
the index was stronger than any single behaviour of the index.  
 
We only included modifiable lifestyle behaviours in the index if there was sufficient 
evidence that they were specifically associated with GC(16;19;21), since the aim of 
our study was not to explore the effect of following general cancer prevention 
recommendations of GC risk.(4) This has already been explored within EPIC data34, 
where comparing the 5th to the 1st category of the WCRF/AICR based cancer 
prevention score resulted in a significant 38% decreased risk of GC and 18% 
decreased risk of developing any cancer(36). Therefore, BMI and physical activity, 
two important factors related to many other cancer sites(4) and chronic diseases, 
were not included in the main index due to their non-conclusive associations with 
overall GC. However, BMI was included in the index for analyses of cardia GC, due 
to mounting evidence that overweight and obesity are only related to cardia GC but 
not overall GC(5), as reflected in our results where a normal weight compared to 
overweight/obesity reduced risk of only cardia GC. In addition, physical activity was 
included in the index in sensitivity analyses, but this only resulted in a slightly greater 
reduction in risk of non-cardia GC, in accordance with previous EPIC results(32).  
 
The strengths of this study are its large size, prospective cohort design, long follow-
up and detailed dietary and lifestyle exposure data. In addition, we had histologically 
validated information on different GC anatomic locations and histologic types, which 
is relevant since they may be etiologically heterogeneous(37). Finally, the robustness 
of the results was confirmed by the negligible changes in the results in the sensitivity 
analyses. A study limitation is that the EPIC cohort may be healthier than the general 
population, since the participants were volunteers. In addition, PARs depend on the 
relative risk and prevalence of risk factors in the studied population, so caution 
should be taken when generalising these results to other populations. Another 
limitation is the construction of the score, which uses dichotomous a priori cut-offs to 
define ‘healthier’ and ‘less healthy’ behaviours for each lifestyle factor. However, the 
definition of the healthy behaviours was predominantly based on public health 
recommendations(2;4) and the advantage of dichotomous compared to continuous 
scoring is that relevant findings can be more easily translated into clearer public 
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health recommendations. The index also gives equal weight to each of the lifestyle 
factors included, although certain factors might be more or less related to GC.  
 
We used an rMED score to represent an overall healthy diet; however processed and 
red meat, fruit and vegetables are the predominantly relevant dietary components for 
GC aetiology(19;21), so it could be argued that these should have been included into 
the lifestyle score directly. However, the advantage of using a dietary score is that it 
takes into account the complexity of the diet, including dietary interactions and other 
possibly relevant dietary components. Although we adjusted for potential 
confounders in the multivariate models, we cannot rule out some residual 
confounding as the lifestyle variables were mostly self-reported. Finally, Hp infection, 
an established causal risk factor for GC(4), was not controlled for in the analyses 
because principal evidence from prospective studies indicate that Hp infection is a 
necessary condition only in the development of non-cardia GC(38) and is not a risk 
factor for cardia GC. Therefore, Hp infection should not confound the results stratified 
by anatomical site, which show a clear negative association between the healthy 
lifestyle index and risk of cardia GC, (where Hp infection is not a risk factor) and also 
between the index and non-cardia GC (where Hp infection is a necessary condition in 
all cases). 
  
Our results indicate that following a combination of modifiable healthy lifestyle 
behaviours could dramatically decrease the burden of GC. These findings are 
particularly relevant considering the very poor relative survival rate for GC (25% at 5-
years)(39), which is reported to be worse for cardia GC (20% at 5-years) compared 
to non-cardia GC (31% at 5-years)(40). Understanding the impact of combined 
lifestyle habits on GC risk further underscores the importance of health promotion 
strategies to eradicate cigarette smoking, reduce overweight/obesity, limit alcohol 
consumption if consumed and improve diet quality. 
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Table 1. The distribution of participants and gastric cancer cases according to anatomical location and 
histological type in 10 countries participating in the European Prospective Investigation Into Cancer and 
Nutrition (EPIC) study cohort¹ 
                
  Cohort 
Sample (% 
male) 
Person-
years 
Gastric Cancer 
Country Total2                         
(% male) 
Cardia²  Noncardia²  Intestinal² Diffuse²  
France 64,078 (0) 667,266 19 (0) 6 10 7 5 
Italy 44,271 (31) 497,159 86 (43) 15 54 36 40 
Spain 39,868 (38) 480,937 77 (56) 7 51 32 26 
United Kingdom 71,844 (40) 800,521 86 (74) 42 25 22 12 
The Netherlands 35,142 (36) 415,192 41 (27) 14 18 8 12 
Greece 24,671 (41) 234,846 33 (57) 4 18 12 14 
Germany 48,027 (44) 474,871 91 (73) 19 51 30 43 
Sweden 47,637 (46) 625,067 106 (57) 33 51 26 28 
Denmark 53606 (47) 586,240 102 (56) 48 27 23 19 
Norway 32,406 (0) 315,400 21 (0) 4 10 1 14 
Total 461,550 (30) 5,097,499 662 (60) 192 315 197 213 
 
¹ Study centers per country: France (North-East, North-West, South, South coast); Italy (Florence, Varese, Ragusa, 
Turin, Naples); Spain (Asturias, Granada, Murcia, Navarra, San Sebastian); United Kingdom(Cambridge, Oxford 
[general and health conscious population]); The Netherlands (Bilthoven, Utrecht); Germany (Heildelberg, Potsdam); 
Sweden (Umea, Malmö); Denmark (Aarhus, Copenhagen), Norway (North-West and South-East)               
²The subtypes of GC do not add up to total GCs because cardia and noncardia classifications do not include tumors of 
unknown or mixed locations (n=155) and intestinal and diffuse classifications do not include unknown, unclassified or 
mixed  morphologies (n=252) 
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Table 2. Baseline characteristics of the 461,550 participants in the European Prospective Investigation Into Cancer and Nutrition (EPIC) 
cohort according to the Healthy Lifestyle Index 
              
Characteristics 
Total    
Cohort 
Healthy Lifestyle Index 1 
0 1 2 3 p-values 
No. Participants 461,550 30,907 130,563 200,501 99,579  
No. Gastric Cancer Cases 662 70 239 245 108  
Index Components       
  Alcohol, g/day (SD) 11.6 (16.9) 39.0 (24.4) 17.0 (19.7) 7.7 (10.9) 3.9 (4.9) <0.001 
  Smoking, % never 44.5 0 14.7 53.7 78.8 <0.001 
  MD score, mean (SD) 7.8 (3.1) 5.6 (1.9) 6.4 (2.6) 7.6 (2.9) 10.9 (1.6) <0.001 
  BMI, kg/m2, mean (SD) 25.4 (4.3) 25.0 (3.9) 25.2 (4.1) 25.4 (4.2) 25.8 (4.7) <0.001 
Covariates       
  Gender, male (%) 29.8 43.7 35.8 29.6 17.9 <0.001 
  Age at recruitment, mean years (SD) 51.2 (9.9) 51.8 (8.4) 50.9 (9.3) 51.3 (10.1) 51.3 (10.8) <0.001 
  Energy intake, mean kcal/day (SD) 2,075 (619) 2,355 (659) 2,152 (651) 2,055 (599) 1,929 (555) <0.001 
  Physical activity, % moderate/high activity 
level 39.5 48 42.2 39.6 33.1 <0.001 
  Waist circumference, % below ATPIII cut-offs 60.1 68.3 58.1 59.5 61.6 <0.001 
  Education, % secondary/university education 45.6 49.2 44.1 46.3 45.3 <0.001 
              
        
Abbreviations; SD: standard deviation. BMI: body mass index. ATPIII: National Cholesterol Education Program’s Adult Treatment 
Panel III 
¹ Healthy Lifestyle Index includes three behavioural components; smoking status, Mediterranean diet score and alcohol consumption.  
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Table 3. Hazard ratios for gastric cancer risk in relation to each single lifestyle factors within the Healthy Lifestyle Index 
  
All Gastric Cancer   Cardia Gastric Cancer   
Non Cardia Gastic 
Cancer 
  
Healthy Iifestyle index component Score 
No. 
Cases  
HR (95% CI)             
p-
value 
No. 
Cases  
HR (95% CI)             
p-
value 
No. 
Cases  
HR (95% CI)             
p-
value 
           
Smoking           
Current or quit for ≤10y 0 309 1 [Reference]  97 1 [Reference]  141 1 [Reference]  
Never smokers or quit for >10y 1 353 0.64 (0.54, 0.75) <0.001 95 0.56 (0.41, 0.75) <0.001 174 0.67 (0.53, 0.86) 0.001 
Alcohol consumption1           
Moderate/ high intake                       
(women >12.5g/d, men >25g/d) 0 182 1 [Reference]  47 1 [Reference]  90 1 [Reference]  
No/ low intake                                               
(women ≤12.5g/d, men ≤25g/d) 1 480 0.83 (0.69, 1.00) 0.058 145 1.08 (0.75, 1.54) 0.682 225 0.74 (0.56, 0.97) 0.027 
Mediterranean diet score2           
≤ 8 points 0 442 1 [Reference]  155 1 [Reference]  184 1 [Reference]  
> 8 points 1 220 0.87 (0.69, 1.09) 0.220 37 0.61 (0.38, 0.97) 0.035 131 1.11 (0.80, 1.54) 0.539 
Body Mass Index3           
Overweight/ obese ( ≥25kg/m2) and 
underweight (<18.5kg/m2) 0 415 1 [Reference]  126 1 [Reference]  202 1 [Reference]  
Normal (18.5 to <25 kg/m2) 1 247 1.02 (0.86, 1.20) 0.827 66 0.80 (0.59, 1.09) 0.166 113 0.99 (0.77,1.27) 0.928 
           
Cox proportional hazards models mututally adjusted for all components of the healthy lifestyle index and additionally adjusted for physical activity, educational attainment, total 
energy intake, and stratified by sex, country and age at recruitment.  
1Acohol intake cutoffs are calculated in accordance with WCRF/AICR guidelines 
2Mediterranean diet score (0-16 points): based on methodology used in previous EPIC article on MD and gastric cancer (Buckland et al. AJCN. 2009), but 
excluding alcohol intake. 
3Body Mass Index: only included in analyses of cardia gastric cancer.   
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Table 4. Hazard ratios for gastric cancer risk, according to anatomical site and histological type, in relation to the Healthy Lifestyle Index 
Gastric Cancer 
N 
Cases 
Healthy Lifestyle Index Score (categorical)1 Healthy Lifestyle 
score (+1-point) 
P-value 
trend 0 1 2 3 4 
 All2 662 [Reference] 0.78 (0.59, 1.03) 0.50 (0.38, 0.66) 0.49 (0.35, 0.70) - 0.75 (0.67, 0.83) <0.001 
 Men  381 [Reference] 0.69 (0.50, 0.95) 0.44 (0.31, 0.62) 0.42 (0.27, 0.67) - 0.71 (0.62, 0.81) <0.001 
 Women 281 [Reference] 1.02 (0.60, 1.72) 0.64 (0.38, 1.08) 0.66 (0.37, 1.19) - 0.80 (0.68, 0.94) 0.007 
Anatomical site3        
  Cardia 192 [Reference] 0.79 (0.44, 1.40) 0.64 (0.36, 1.15) 0.42 (0.22, 0.80) 0.23 (0.08, 0.68) 0.74 (0.62, 0.87) <0.001 
  Non Cardia 315 [Reference] 0.72 (0.48, 1.10) 0.48 (0.32, 0.74) 0.53 (0.32, 0.87) - 0.78 (0.67, 0.90) 0.001 
Histological type4        
  Diffuse  213 [Reference] 0.98 (0.58, 1.66) 0.62 (0.36, 1.06) 0.52 (0.27, 0.99) - 0.75 (0.63, 0.90) 0.002 
  Intestinal 197 [Reference] 0.66 (0.40, 1.09) 0.37 (0.22, 0.63) 0.49 (0.27, 0.90) - 0.74 (0.61, 0.89) 0.002 
      -   
Cox proportional hazards models adjusted by BMI (except in cardia and non-cardia models), physical activity, educational attainment, total energy intake, and stratified by sex, 
country and age at recruitment.  
1In analyses of all gastric cancers and non-cardia, diffuse and intestinal subtypes, the healthy lifestyle index includes 3 behavioural components; smoking status, Mediterranean 
diet score and alcohol consumption. An additional 4th component, BMI, is included in analyses of only cardia gastric cancer. 
2Test for interaction by sex not significant (p=0.767)      
3Test for heterogeneity by anatomical location not significant (p=0.468)     
4Test for heterogeneity by histological type not significant (p=0.877)     
 
